NCT03693807View on ClinicalTrials.gov

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

June 27, 2024

Study Completion Date

June 27, 2024

Conditions
Colorectal CancerCholangiocarcinoma
Interventions
DEVICE

Medtronic pump and Codman catheter

All patients will undergo surgery to have the Medtronic pump and Codman catheter placed appropriately before HAI therapy can begin.

DRUG

Floxuridine (FUDR)

Please see Detailed Description.

DRUG

Gemcitabine

Please see Detailed Description.

DRUG

Oxaliplatin

Please see Detailed Description.

DRUG

Irinotecan (CPT-11)

Please see Detailed Description.

DRUG

Fluorouracil

Please see Detailed Description.

DRUG

Anti-EGFR (Panitumumab or Cetuximab)

Please see Detailed Description.

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11553

Memorial Sloan Kettering Nassau, Uniondale

11725

Memorial Sloan Kettering Commack, Commack

07920

Memorial Sloan Kettering Basking Ridge, Basking Ridge

07748

Memorial Sloan Kettering Monmouth, Middletown

07645

Memorial Sloan Kettering Bergen, Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03693807 - A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma | Biotech Hunter | Biotech Hunter